Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × dabrafenib × 1 year × Clear all

Sponsor

Conditions

Melanoma 16 Glioma 6 Thyroid Carcinoma, Anaplastic 5 Carcinoma, Non-Small-Cell Lung 5 Thyroid Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Colorectal Neoplasms 3 Thyroid Cancer, Papillary 2 Skin Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Hematologic Neoplasms 2 Glioblastoma 2 Fever 2 Brain Neoplasms 2 Astrocytoma 2 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1 Sarcoma 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Rare Malignant Neoplasm 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1

Interventions

pembrolizumab 104 Cisplatin 28 lenvatinib 26 Paclitaxel 24 Carboplatin 24 Pemetrexed 13 Gemcitabine 9 Docetaxel 9 Saline Solution 8 Fluorouracil 8 Capecitabine 7 olaparib 6 Oxaliplatin 6 Bevacizumab 6 Albumin-Bound Paclitaxel 6 epacadostat 5 Etoposide 5 Cetuximab 5 belzutifan 4 Leucovorin 4 130-nm albumin-bound paclitaxel 4 patritumab deruxtecan 3 enzalutamide 3 durvalumab 3 Glucose 3 Dexamethasone 3 Acetaminophen 3 trifluridine tipiracil drug combination 2 regorafenib 2 liposomal doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡